HeartSciences Inc.

HSCS

HeartSciences Inc.

HSCS

Insider Sentiment (TTM):

Last Purchase:-Last Sale:2025-07-29Shares Purchased (TTM):0Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:180,453Shares Outstanding:2,625,421Institutional Ownership Pct.:6.87%

Earnings Market Reaction:

Filing Date:2026-07-23Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-04-30	2026-01-31	2025-10-31	2025-07-31	2025-04-30	2025-01-31	2024-10-31	2024-07-31	2024-04-30	2024-01-31	2023-10-31	2023-07-31
Series A B C Convertible Preferred Stock	-	-	-	-	0	0	0	0	0	0	0	0
Cash And Cash Equivalents At Carrying Value	2	3	2	3	1	3	4	4	6	7	0	1
Accounts Receivable Net Current	-	0	-	-	0	-	-	-	-	0	0	-
Assets
Assets Current
Inventory Net	1	1	1	1	1	1	1	1	1	1	1	1
Prepaid Expense Current	-	0	0	0	0	0	0	0	0	0	0	0
Deferred Offering Costs	0	1	1	1	0	0	1	1	1	1	1	0
Other Assets Current	-	0	0	0	0	0	0	0	0	0	0	0
Assets Current	-	5	4	4	2	4	6	6	7	9	2	2
Property Plant And Equipment Net	0	0	0	0	0	0	0	0	0	0	0	0
Capitalized Computer Software Net	1	0	0	-	-	-	-	-	-	-	-	-
Finite Lived Intangible Assets Net	-	-	2	2	2	2	2	2	2	2	-	-
Intangible Assets Net Excluding Goodwill	-	2	-	-	-	-	-	-	-	-	-	-
Operating Lease Right Of Use Asset	0	0	0	0	0	0	0	0	0	0	1	1
Assets	-	8	6	6	4	6	8	8	10	11	2	3
Liabilities Current
Accounts Payable Current	-	0	0	0	0	0	0	0	0	0	1	0
Accrued Liabilities Current	-	-	0	1	1	0	0	0	0	1	1	1
Interest Payable Current	-	0	0	0	0	0	0	-	0	-	-	-
Liabilities And Stockhold…
Operating Lease Liability Current	0	0	0	0	0	0	0	0	0	0	0	0
Notes Payable Current	4	3	1	2	3	3	2	0	1	1	1	1
Other Liabilities Current	-	0	0	0	0	0	0	0	0	0	0	0
Liabilities Current	-	4	2	3	4	4	3	1	2	2	4	2
Liabilities Noncurrent
Long Term Notes Payable	-	0	-	-	-	-	0	1	0	-	-	1
Accounts Payable And Accrued Liabilities Noncurren…	-	-	-	-	-	-	0	-	0	-	-	0
Operating Lease Liability Noncurrent	0	0	0	0	0	0	0	0	0	0	0	1
Liabilities Noncurrent	-	1	0	0	0	0	0	1	0	0	0	1
Liabilities	-	5	2	3	4	4	4	2	2	2	4	3
Stockholders Equity
Common Stock Value	-	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	-	85	85	81	76	76	76	75	75	74	62	62
Retained Earnings Accumulated Deficit	-85	-83	-81	-78	-76	-74	-71	-69	-67	-66	-64	-62
Stockholders Equity	0	3	4	3	0	2	4	6	7	9	-2	-1
Liabilities And Stockholders Equity	-	8	6	6	4	6	8	8	10	11	2	3
Series C Convertible Preferred Stock	-	-	0	0	-	-	0	0	-	-	-	-
Series D Convertible Preferred Stock	-	-	0	0	-	0	-	-	-	-	-	-
Preferred Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Preferred Stock Shares Authorized	20	20	20	20	20	20	20	20	20	20	20	20
Preferred Stock Shares Issued	-	-	-	-	0	-	-	-	0	-	-	-
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	500	500	500	500	500	500	500	500	500	500	500	500
Common Stock Shares Issued	3	3	3	2	1	1	1	1	1	1	0	0
Shares Outstanding	-	3	3	2	1	1	1	1	1	1	0	0

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	10.78%	-8.68%	-19.76%	32.79%	21.05%	6.88%	-21.80%	-27.44%	-27.07%	-	-	-
2025	55.56%	3.94%	5.73%	-11.69%	-1.25%	-25.12%	-11.07%	18.23%	15.99%	-13.99%	-23.54%	-11.20%
2024	-51.34%	-71.83%	-72.68%	5.70%	-15.82%	-23.42%	-12.00%	-28.80%	-56.00%	-9.49%	-27.25%	-13.38%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-04-30	2026-01-31	2025-10-31	2025-07-31	2025-04-30	2025-01-31	2024-10-31	2024-07-31	2024-04-30	2024-01-31	2023-10-31	2023-07-31
Liquidity Ratios
Current Ratio	-	1.19	2.42	1.47	0.59	1.02	1.72	4.49	4.20	5.09	0.51	1.07
Quick Ratio	-	1.00	1.86	1.11	0.39	0.78	1.45	3.73	3.73	4.56	0.22	0.47
Working Capital	-	829.93K	2.23M	1.40M	-1.53M	57.63K	2.39M	4.72M	5.60M	6.98M	-1.72M	131.31K
Leverage & Debt
Debt to Equity	-	1.85	0.43	1.05	19.58	2.19	0.94	0.38	0.30	0.25	-2.44	-6.00
Interest Coverage TTM	-11.17	-11.05	-10.00	-12.32	-16.69	-24.41	-26.71	-20.72	-17.81	-16.41	-20.64	-44.27
Debt Ratio	-	0.65	0.30	0.51	0.95	0.69	0.48	0.28	0.23	0.20	1.70	1.20
Efficiency & Turnover
Asset Turnover TTM	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Sales Outstanding TTM	-	-	-	-	365.00	-	-	-	-	288.47	243.33	-
Receivables Turnover TTM	-	-	-	-	1.00	-	-	-	-	1.27	1.50	-
Per Share Metrics
Diluted EPS TTM	-	-	-3.25	-6.73	-9.34	-8.64	-8.31	-9.37	-18.74	-11.69	-55.44	-59.51
Free Cash Flow Per Share TTM	-2.84	-2.33	-2.71	-5.66	-7.93	-7.57	-8.66	-8.67	-17.40	-11.67	-48.18	-52.09
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Operating Profit Margin TTM	-194,787.38%	-89,939.57%	-95,044.33%	-130,416.37%	-192,013.13%	-	-50,788.24%	-37,907.43%	-33,901.99%	-32,390.53%	-99,291.62%	-308,385.74%
Net Profit Margin TTM	-211,666.47%	-97,880.97%	-104,237.92%	-140,296.54%	-201,499.52%	-	-51,867.90%	-39,193.77%	-35,511.87%	-34,362.39%	-104,097.59%	-315,273.95%
Growth Metrics
Net Revenue Growth (1Y)	-0.71%	-	-41.03%	-66.40%	-76.61%	-100.00%	151.28%	853.85%	261.17%	-	-	-
Net Income Growth (1Y)	4.30%	-0.37%	18.52%	20.28%	32.70%	33.26%	25.20%	18.58%	3.95%	-	-	-
EPS Growth (1Y)	-62.73%	-68.93%	-60.89%	-28.23%	-50.14%	-26.12%	-85.01%	-84.25%	-76.56%	-	-	-
Valuation Metrics
P/E TTM	-0.56	-1.20	-0.94	-0.46	-0.38	-0.37	-0.35	-0.41	-0.49	-1.28	-0.45	-1.47
P/B TTM	22.65	3.85	2.03	1.29	16.03	1.78	0.67	0.50	0.44	0.95	-1.66	-17.34
P/S TTM	1,185.36	1,178.23	978.26	650.72	756.00	-	183.49	160.99	174.36	440.86	467.53	4,620.03
Market Cap	5.12M	10.21M	8.48M	4.07M	3.29M	3.18M	2.70M	2.99M	3.24M	8.20M	2.74M	9.01M
Enterprise Value	7.04M	10.34M	7.03M	2.82M	4.74M	3.11M	1.06M	-845.46K	-2.06M	1.62M	4.05M	9.43M
Calculated Values
Free Cash Flow TTM	-7.45M	-7.37M	-7.54M	-7.38M	-7.44M	-7.47M	-7.94M	-6.75M	-6.13M	-6.38M	-5.29M	-5.38M
Net Debt	1.92M	124.25K	-1.45M	-1.25M	1.45M	-70.30K	-1.64M	-3.84M	-5.31M	-6.58M	1.32M	424.35K
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2025-07-29Sale

Owner: Hilz, Mark T

Title: COO, Secretary and Director

Shares: 4,416

Price/Share: $3.54

Value: $15,632.64

Shares Owned: 4,752

Relationship: Director,Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2025-07-29	Hilz, Mark T	Director,Officer	COO, Secretary and Director	Direct	Sale	4,416	3.54	$15,632.64	4,752	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

6.87%

Inst. Shares: 180,453

Shares Outstanding: 2,625,421

2025-12-31

6.24%

Inst. Shares: 197,469

Shares Outstanding: 3,162,257

2025-09-30

6.30%

Inst. Shares: 175,223

Shares Outstanding: 2,780,496

2025-06-30

4.62%

Inst. Shares: 60,285

Shares Outstanding: 1,303,532

2025-03-31

2.50%

Inst. Shares: 23,494

Shares Outstanding: 938,257

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	180,453	2,625,421	6.87%
2025-12-31	197,469	3,162,257	6.24%
2025-09-30	175,223	2,780,496	6.30%
2025-06-30	60,285	1,303,532	4.62%
2025-03-31	23,494	938,257	2.50%
2024-12-31	1,413	986,057	0.14%
2024-09-30	2,881	917,445	0.31%
2024-06-30	10,252	777,746	1.32%
2024-03-31	1,432,568	352,520	-
2023-12-31	780,728	546,670	142.82%
2023-09-30	349,363	109,841	-
2023-06-30	406,762	103,315	-
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

HeartSciences Inc. (HSCS) — SEC Financial Statements & Analysis

HeartSciences Inc. (HSCS) is a finance services company, incorporated in TX. HeartSciences Inc. trades on Nasdaq as: HSCS, HSCSW. Based on its latest SEC filing (Form 10-Q, period ending 2026-04-30), HeartSciences Inc. reported a -0.71% year-over-year revenue growth, a Debt-to-Equity ratio of 1.85x, a Price-to-Sales (P/S) ratio of 1185.36x (TTM), a Price-to-Book (P/B) ratio of 22.65x (TTM), at a market cap of $5.12M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: -0.71%
Debt To Equity: 1.85x
P/S TTM: 1185.36x
P/B TTM: 22.65x
Market Cap: $5.12M

Data as of 2026-04-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is HeartSciences Inc. in?

HeartSciences Inc. (HSCS) operates in the Finance Services industry.

What is HSCS's market cap?

HeartSciences Inc. (HSCS) has a market capitalization of $5.12M as of 2026-04-30.

What exchange does HSCS trade on?

HeartSciences Inc. (HSCS) trades on the Nasdaq.

Where is HeartSciences Inc. incorporated?

HeartSciences Inc. is incorporated in TX.